Mar. 5 at 3:56 PM
$PACS some interesting perspectives from the post-earnings RBC report which I just got access to.
- Raised price target from
$47 to
$52 with PACS as a top pick for 2026
- Noted they would be strong buyers on weakness and see little justification for the magnitude of the sell-off
- Noted three areas of feedback from investors including 1) concerns about organic growth given revenue guidance of only 8% at the midpoint, 2) slight degradation in occupancy and skilled mix in the non-mature facility cohorts, and 3) managment not addressing the ongoing DOJ investigation